Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264823 · ClinicalTrials.gov registry record · Phase 2
Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)
A Phase 2 study of HIV and Mental Illness, sponsored by National Institute of Nursing Research (NINR).
- Completed
- Registry status
- Phase 2
- Development phase
- 273
- Enrollment target
- 1
- Study location
NCT00264823 is a Phase 2 study of HIV and Mental Illness that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 273 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00264823, a Phase 2 study of HIV and Mental Illness, has completed, sponsored by National Institute of Nursing Research (NINR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate how nurses can best help people with serious mental illnesses (SMI) follow their HIV treatment plans.
Conditions Studied
Interventions
- BEHAVIORAL Use of Memory Aids to take medications
Study Locations (1)
Pennsylvania
- Center for Mental Health Services and Policy Research - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00264823
The ClinicalTrials.gov registry entry for NCT00264823 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (38% lower). The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Use of Memory Aids to take medications is the first listed.
NCT00264823 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00264823 about?
NCT00264823 is a clinical study titled "Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)". The purpose of this research study is to investigate how nurses can best help people with serious mental illnesses (SMI) follow their HIV treatment plans.
What is the current status of trial NCT00264823?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 273 participants. The study started on 2003-06. Estimated completion is 2008-05.
What conditions does trial NCT00264823 study?
This clinical trial studies the following conditions: HIV, Mental Illness.
What interventions are being tested in trial NCT00264823?
The interventions under investigation include: Use of Memory Aids to take medications (BEHAVIORAL).
Who is sponsoring clinical trial NCT00264823?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00264823 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.